These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 25994830)
1. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart. Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830 [TBL] [Abstract][Full Text] [Related]
2. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats. Bai F; Zhang LH; Zhang WW; Zheng RH; Eskew JR; Bennett J; Wang NP; Bose HS; Zhao ZQ Eur J Pharmacol; 2020 Jan; 867():172844. PubMed ID: 31811859 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Pang XF; Zhang LH; Bai F; Wang NP; Garner RE; McKallip RJ; Zhao ZQ Drug Des Devel Ther; 2015; 9():6043-54. PubMed ID: 26648693 [TBL] [Abstract][Full Text] [Related]
4. Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension. Banks TE; Rajapaksha M; Zhang LH; Bai F; Wang NP; Zhao ZQ Eur J Pharmacol; 2022 Jul; 927():175048. PubMed ID: 35644422 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis. Bai F; Pang XF; Zhang LH; Wang NP; McKallip RJ; Garner RE; Zhao ZQ Life Sci; 2016 May; 153():141-52. PubMed ID: 27085217 [TBL] [Abstract][Full Text] [Related]
6. Postconditioning attenuates coronary perivascular and interstitial fibrosis through modulating angiotensin II receptors and angiotensin-converting enzyme 2 after myocardial infarction. Wang ZF; Wang NP; Harmouche S; Philip T; Pang XF; Bai F; Zhao ZQ J Surg Res; 2017 May; 211():178-190. PubMed ID: 28501115 [TBL] [Abstract][Full Text] [Related]
7. Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats. Zheng RH; Bai XJ; Zhang WW; Wang J; Bai F; Yan CP; James EA; Bose HS; Wang NP; Zhao ZQ Drug Des Devel Ther; 2019; 13():2745-2757. PubMed ID: 31496651 [TBL] [Abstract][Full Text] [Related]
8. Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro. Wang XW; Zhang FX; Yang F; Ding ZF; Agarwal N; Guo ZK; Mehta JL Acta Pharmacol Sin; 2016 Sep; 37(10):1349-1358. PubMed ID: 27498780 [TBL] [Abstract][Full Text] [Related]
9. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor. Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650 [TBL] [Abstract][Full Text] [Related]
10. Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II. Wang NP; Erskine J; Zhang WW; Zheng RH; Zhang LH; Duron G; Gendreau J; Zhao ZQ J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317706653. PubMed ID: 28490219 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts. Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700 [TBL] [Abstract][Full Text] [Related]
12. Fibrous tissue and angiotensin II. Sun Y; Ramires FJ; Zhou G; Ganjam VK; Weber KT J Mol Cell Cardiol; 1997 Aug; 29(8):2001-12. PubMed ID: 9281434 [TBL] [Abstract][Full Text] [Related]
13. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice. Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054 [TBL] [Abstract][Full Text] [Related]
15. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together. Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181 [TBL] [Abstract][Full Text] [Related]
16. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222 [TBL] [Abstract][Full Text] [Related]